Literature DB >> 411667

Influence of cholic and chenodeoxycholic acid on biliary cholesterol secretion in man.

L Lindblad, K Lundholm, T Scherstén.   

Abstract

The interrelationships between biliary bile acid, lecithin and cholesterol secretion rates were studied druing depletion of the bile acid pool and during duodenal administration of cholic or chenodeoxycholic acid in thirteen patients 7-12 days after operation for uncomplicated gallstone disease. The mean lecithin secretion rate was signigicantly higher during cholic acid than during chenodeoxycholic acid infusion. The relationship between bile acid and cholesterol secretion rates was curvilinear, y = x/(a + bx) during bile acid pool depletion and during duodenal cholic acid infusion. At low bile acid secretion rates, during bile acid pool depletion and during cholic acid infusion, the lecithin secretion rate was significantly correlated to the cholesterol secreation rate. The bile acid and cholesterol secretion rates were not significantly correlated during chenodeoxycholic acid infusion. However, under this experimental condition a significant curvilinear relationship between lecithin and cholesterol secretion rates was found. The hepatic bile became unsaturated in cholesterol at significantly lower bile acid secretion rate during chenodeoxycholic acid infusion (10.7 +/- 0.3 mumol min-1) than during cholic acid infusion (15.6 +/- 0.5 mumol min-1).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 411667     DOI: 10.1111/j.1365-2362.1977.tb01623.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

1.  Effects of interruption of enterohepatic circulation on biliary lipid secretion in man.

Authors:  H Y Mok; K von Bergmann; S M Grundy
Journal:  Am J Dig Dis       Date:  1978-12

2.  Cholesterol esterase activity of human intestinal mucosa.

Authors:  M Ponz de Leon; F Carubbi; P Di Donato; N Carulli
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

3.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

Authors:  G T Everson; C McKinley; F Kern
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

4.  Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.

Authors:  T J Meredith; G V Williams; P N Maton; G M Murphy; H M Saxton; R H Dowling
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

5.  Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.

Authors:  S Güldütuna; M Leuschner; N Wunderlich; A Nickel; S Bhatti; K Hübner; U Leuschner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Gallbladder and small intestinal regulation of biliary lipid secretion during intraduodenal infusion of standard stimuli.

Authors:  G T Everson; M J Lawson; C McKinley; R Showalter; F Kern
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle.

Authors:  F Kern; G T Everson; B DeMark; C McKinley; R Showalter; W Erfling; D Z Braverman; P Szczepanik-van Leeuwen; P D Klein
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

Review 8.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

9.  Effects of acute changes of bile acid pool composition on biliary lipid secretion.

Authors:  N Carulli; P Loria; M Bertolotti; M Ponz de Leon; D Menozzi; G Medici; I Piccagli
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

Review 10.  Pharmacological treatment of gallstones. Practical guidelines.

Authors:  A Lanzini; T C Northfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.